Mireille Cantarini

13.2k citations
81 papers · 8.1k indexed · 8 hit papers · h-index 33
Topics
Lung Cancer Treatments and Mutations (61 papers)Colorectal Cancer Treatments and Studies (22 papers)Cancer Genomics and Diagnostics (17 papers)

In The Last Decade

Mireille Cantarini

80 papers receiving 8.0k citations

Hit Papers

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung C...20152026201820222015201520162016201650010001.5k

Peers

Mireille Cantarini
Comparison fields: 5 of 100
  • Pulmonary and Respiratory Medicine 6.1k
  • Oncology 5.1k
  • Molecular Biology 3.2k
  • Cancer Research 2.4k
  • Pathology and Forensic Medicine 597
Replace Sara M. Haserlat with:
Sara M. Haserlat United States
Sean Tracy United States
Patricia L. Harris United States
Hidefumi Sasaki Japan
Paula Herman United States
Daniel B. Costa United States
Juliann Chmielecki United States
Ross A. Okimoto United States
Alison Armour United Kingdom
Claire Watkins United Kingdom
Mireille Cantarini relative to Sara M. Haserlat United States Sara M. Haserlat's profile →
Citations per field
00.5×3.7×
Sara M. Haserlat · 1×
Citations per year

Countries citing papers authored by Mireille Cantarini

Since Specialization
Citations

This map shows the geographic impact of Mireille Cantarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireille Cantarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireille Cantarini more than expected).

Fields of papers citing papers by Mireille Cantarini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireille Cantarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireille Cantarini. The network helps show where Mireille Cantarini may publish in the future.

Co-authorship network of co-authors of Mireille Cantarini

This figure shows the co-authorship network connecting the top 25 collaborators of Mireille Cantarini. A scholar is included among the top collaborators of Mireille Cantarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireille Cantarini. Mireille Cantarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTONbreakdown →
95
2 10
3 50
4 221
5 2
6 46
7 17
8 23
9
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activitybreakdown →
523
10 11
11
Design, execution, and preliminary biomarker results from paired tumor biopsy cohorts of the AZD9291 AURA trial
1
12 15
13 218
14 25
15 176
16 132
17 14
18 78
19 23
20 92

About Mireille Cantarini

Mireille Cantarini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 81 papers that have together received 8.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (61 papers), Colorectal Cancer Treatments and Studies (22 papers) and Cancer Genomics and Diagnostics (17 papers). The work is most often cited by research in Oncology (5.1k citations), Pulmonary and Respiratory Medicine (6.1k citations) and Cancer Research (2.4k citations). Mireille Cantarini has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include Pasi A. Jänne, James Chih‐Hsin Yang, Kenneth S. Thress, J. Carl Barrett, Enriqueta Felip, Geoffrey R. Oxnard, Myung‐Ju Ahn, Cloud P. Paweletz, Suresh S. Ramalingam and Paul Frewer. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026